Concepedia

Author

Emmanuel Brousseau

Physiogenex (France)

Also Known As

Brousseau Emmanuel, Brousseau, E., E. Brousseau, EMMANUEL BROUSSEAU, Emmanuel Brousseau

22

Publications

272

Citations

6

H-Index

15

Concepts

All Affiliations

Physiogenex (France)InsermHôpital Rangueil
EB

About

Emmanuel Brousseau is an author at Physiogenex (France) specializing in host-microbe interactions, nutrition, and diabetes.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

41

2

Medicine

1

1

41

3

Biochemistry

1

1

41

4

Diabetes

1

1

41

5

Immunology

1

1

41

Emmanuel Brousseau

×

6

Publications

262

Citations

6

H-Index

YearCitations

Empagliflozin, via Switching Metabolism Toward Lipid Utilization, Moderately Increases LDL Cholesterol Levels Through Reduced LDL Catabolism

François Briand, Eric Mayoux, Emmanuel Brousseau,

Diabetes

2016

109

Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model

François Briand, Emmanuel Brousseau, Marjolaine Quinsat,

European Journal of Pharmacology

2017

41

Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion

J. Charpentier, François Briand, Benjamin Lelouvier,

Acta Diabetologica

2021

41

Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters

François Briand, Julie Maupoint, Emmanuel Brousseau,

Metabolism

2021

29

Evaluation of Antiatherogenic Properties of Ezetimibe Using<sup>3</sup>H-Labeled Low-Density-Lipoprotein Cholesterol and<sup>99m</sup>Tc-cAbVCAM1–5 SPECT in ApoE<sup>−/−</sup>Mice Fed the Paigen Diet

Laurent Dumas, François Briand, Romain Clerc,

Journal of Nuclear Medicine

2017

22

A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death

François Briand, Christophe Heymes, Lucile Bonada,

Clinical and Translational Science

2020

20

Page 1